ERBB2 and neoplasm: In an approach to target multiple tumor antigens with the same adoptively-transferred CTL, a chimeric antigen receptor (CAR) specific for the human epidermal growth factor receptor 2 (HER2) has been introduced into EBV-specific DNR-CTL generated from the blood of EBV seropositive patients for investigation in patients with HER2+ malignancies.